Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00494351 · ClinicalTrials.gov registry record · NA
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
A NA study of Hidradenitis Suppurativa, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00494351: Completed NA study of Hidradenitis Suppurativa, sponsored by Henry Ford Health System.
NCT00494351 is a NA study of Hidradenitis Suppurativa that has completed, run by Henry Ford Health System. The registered enrollment target is 20 participants, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00494351, a NA study of Hidradenitis Suppurativa, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
* Determination of the short and long term efficacy of NdYag laser for treatment of Hidradenitis suppurativa, which is an inflamed, deeper follicular disorders. * Determination of patient tolerance of discomfort associated with NdYag laser treatment for Hidradenitis suppurativa. * Determination of the impact of this condition on quality of life and if there is any impact of therapy in the dermatology quality of life index. * Evaluate the histopathologic changes of YAG therapy on affected skin Second phase of study: * Prospective, controlled clinical and histologic study of patients with Hurley Stage II HS disease. * 19 patients of skin types II to VI with Hurley Stage II hidradenitis suppurativa lesions of the axilla and groin. This is a different set of patients than those treated in the first phase of the study above. This study primarily focuses on and further characterizes the histologic changes after laser treatment.
Conditions Studied
Interventions
- PROCEDURE Long-pulsed Nd:YAG laser 1064 nm
Study Locations (1)
Michigan
- Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard, - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-07 |
| Phase | NA |
What the finished NCT00494351 record still lists
NCT00494351 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 1 intervention - of which Long-pulsed Nd:YAG laser 1064 nm is the first listed.
NCT00494351 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00494351 about?
NCT00494351 is a clinical study titled "Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa". * Determination of the short and long term efficacy of NdYag laser for treatment of Hidradenitis suppurativa, which is an inflamed, deeper follicular disorders. * Determination of patient tolerance of discomfort associated with NdYag laser treatment for Hidradenitis suppurativa. * Determination of t...
What is the current status of trial NCT00494351?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2007-06. Estimated completion is 2009-07.
What conditions does trial NCT00494351 study?
This clinical trial studies the following conditions: Hidradenitis Suppurativa.
What interventions are being tested in trial NCT00494351?
The interventions under investigation include: Long-pulsed Nd:YAG laser 1064 nm (PROCEDURE).
Who is sponsoring clinical trial NCT00494351?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00494351 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hidradenitis Suppurativa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00494351's enrollment target sits among peer trials
20 41st of 52 higher than 9 of 52 other Hidradenitis Suppurativa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hidradenitis Suppurativa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Aviclear for Hidradenitis Suppurativa (HS)
RECRUITING · NA
-
Physical Activity in Hidradenitis Suppurativa (HS)
RECRUITING · NA
-
Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
RECRUITING · NA
-
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
RECRUITING · NA
-
Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
COMPLETED · NA
-
Hidradenitis Suppurativa (HS) Tunneling Wounds
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia